- The round was led by Cove Fund II, a prominent Life Science and Tech VC fund. - Funds will be deployed to commercialize its data driven surgery mission. - Carlsmed expands team of executive officers adding CFO and CIO. SAN DIEGO--( BUSINESS WIRE )-- Carlsmed, Inc., a San Diego-based MedTech company, today announced the close of an oversubscribed $2.5M seed round. The round was led by Cove Fund II, a prominent California Life Science and Technolog
June 23, 2020
· 3 min read